Evogene Ltd. (TLV:EVGN)

Evogene Statistics

Total Valuation

Evogene has a market cap or net worth of ILS 25.42 million. The enterprise value is 29.56 million.

Market Cap	25.42M
Enterprise Value	29.56M

Important Dates

The next estimated earnings date is Wednesday, May 20, 2026.

Earnings Date	May 20, 2026
Ex-Dividend Date	n/a

Share Statistics

Evogene has 9.89 million shares outstanding. The number of shares has increased by 38.21% in one year.

Current Share Class	9.89M
Shares Outstanding	9.89M
Shares Change (YoY)	+38.21%
Shares Change (QoQ)	+0.02%
Owned by Insiders (%)	0.89%
Owned by Institutions (%)	2.09%
Float	9.81M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.07
PB Ratio	0.67
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-1.09
EV / Sales	2.41
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-0.68

Financial Position

The company has a current ratio of 4.54, with a Debt / Equity ratio of 0.18.

Current Ratio	4.54
Quick Ratio	3.96
Debt / Equity	0.18
Debt / EBITDA	n/a
Debt / FCF	-0.16
Interest Coverage	-87.82

Financial Efficiency

Return on equity (ROE) is -100.69% and return on invested capital (ROIC) is -54.69%.

Return on Equity (ROE)	-100.69%
Return on Assets (ROA)	-28.77%
Return on Invested Capital (ROIC)	-54.69%
Return on Capital Employed (ROCE)	-83.05%
Weighted Average Cost of Capital (WACC)	8.66%
Revenue Per Employee	104,986
Profits Per Employee	-231,198
Employee Count	117
Asset Turnover	0.13
Inventory Turnover	4.04

Taxes

In the past 12 months, Evogene has paid 3,188 in taxes.

Income Tax	3,188
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -44.81% in the last 52 weeks. The beta is 0.95, so Evogene's price volatility has been similar to the market average.

Beta (5Y)	0.95
52-Week Price Change	-44.81%
50-Day Moving Average	286.06
200-Day Moving Average	379.27
Relative Strength Index (RSI)	44.59
Average Volume (20 Days)	37,580

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Evogene had revenue of ILS 12.28 million and -27.05 million in losses. Loss per share was -3.44.

Revenue	12.28M
Gross Profit	-768,308
Operating Income	-43.96M
Pretax Income	-43.03M
Net Income	-27.05M
EBITDA	-42.29M
EBIT	-43.96M
Loss Per Share	-3.44

Balance Sheet

The company has 41.30 million in cash and 7.01 million in debt, with a net cash position of 34.30 million or 3.47 per share.

Cash & Cash Equivalents	41.30M
Total Debt	7.01M
Net Cash	34.30M
Net Cash Per Share	3.47
Equity (Book Value)	38.18M
Book Value Per Share	-0.03
Working Capital	38.85M

Cash Flow

In the last 12 months, operating cash flow was -43.04 million and capital expenditures -430,380, giving a free cash flow of -43.47 million.

Operating Cash Flow	-43.04M
Capital Expenditures	-430,380
Depreciation & Amortization	1.64M
Net Borrowing	-1.64M
Free Cash Flow	-43.47M
FCF Per Share	-4.39

Margins

Gross margin is -6.25%, with operating and profit margins of -357.85% and -220.22%.

Gross Margin	-6.25%
Operating Margin	-357.85%
Pretax Margin	-350.32%
Profit Margin	-220.22%
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Evogene does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-38.21%
Shareholder Yield	-38.21%
Earnings Yield	-106.43%
FCF Yield	-171.05%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on July 28, 2024. It was a reverse split with a ratio of 0.1.

Last Split Date	Jul 28, 2024
Split Type	Reverse
Split Ratio	0.1

Scores

Evogene has an Altman Z-Score of -20.34 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-20.34
Piotroski F-Score	2